Longitudinal cohort studies

Journal of Rheumatology

Volumn 32, Issue SUPPL. 72, 2005, Pages 30-32

  Gladman, Dafna D ^a,c   Farewell, Vernon T ^b  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b MEDICAL RESEARCH COUNCIL   (United Kingdom)

^c TORONTO WESTERN HOSPITAL   (Canada)

Author keywords

Cohort studies; Psoriatic arthritis; Reproducibility of results; Rheumatic diseases

Indexed keywords

CLINICAL FEATURE; CLINICAL TRIAL; COHORT ANALYSIS; COMPUTER ANALYSIS; CONFERENCE PAPER; DATA ANALYSIS; DATA BASE; DISEASE COURSE; DOCTOR PATIENT RELATION; FOLLOW UP; HUMAN; LONGITUDINAL STUDY; MEASUREMENT; OBSERVATION; PATIENT ATTITUDE; PRIORITY JOURNAL; PROGNOSIS; PSORIATIC ARTHRITIS; QUESTIONNAIRE; RHEUMATIC DISEASE; ADULT; CANADA; FACTUAL DATABASE; FEMALE; MALE; MIDDLE AGED; REVIEW; UNIVERSITY HOSPITAL;

ADULT; ARTHRITIS, PSORIATIC; CANADA; DATABASES, FACTUAL; FEMALE; HOSPITALS, UNIVERSITY; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PROGNOSIS;

EID: 17144402200     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (13)

1. Gladman DD, Farewell V, Buskila D, et al. Reliability of measurements of active and damaged joints in psoriatic arthritis. J Rheumatol 1990;17:62-4.
2. Rahman P, Gladman DD, Cook RJ, Zhou Y, Young G, Salonen D. Radiological assessment in psoriatic arthritis. Br J Rheumatol 1998;37:760-5.
3. Blackmore MG, Gladman DD, Husted J, Long JA, Farewell VT. Measuring health status in psoriatic arthritis: the Health Assessment Questionnaire and its modification. J Rheumatol 1995;22:886-93.
4. Husted JA, Gladman DD, Farewell VT, Long JA, Cook RJ. Validating the SF-36 health survey questionnaire in patients with psoriatic arthritis. J Rheumatol 1997;24:511-7.
5. Schentag CT. Cichon J, Mackinnon A, Gladman DD, Urowitz MB. Validation and normative data for the 0-10 point scale version of the fatigue severity scale [abstract]. Arthritis Rheum 2000;43 Suppl:S177.
6. Gladman DD, Shuckett R, Russell ML, Thorne JC, Schachter RK. Psoriatic arthritis (PSA) - an analysis of 220 patients. Q J Med 1987;62:127-41.
7. Gladman DD. The natural history of psoriatic arthritis. Baillieres Clin Rheumatol 1994;8:379-94.
8. Gladman DD, Farewell VT, Nadeau C. Clinical indicators of progression in psoriatic arthritis: multivariate relative risk model. J Rheumatol 1995;22:675-9.
9. Gladman DD, Farewell VT. Progression in psoriatic arthritis: role of time varying clinical indicators. J Rheumatol 1999;26:2409-13.
10. Gladman DD, Hing EN, Schentag CT, Cook RJ. Remission in psoriatic arthritis. J Rheumatol 2001;28:1045-8.
11. Wong K, Gladman DD, Husted J, Long JA, Farewell VT. Mortality studies in psoriatic arthritis: results from a single outpatient clinic. I. Causes and risk of death. Arthritis Rheum 1997;40:1868-72.
12. Gladman DD, Farewell VT, Wong K, Husted J. Mortality studies in psoriatic arthritis: results from a single outpatient center. II. Prognostic indicators for death. Arthritis Rheum 1998;41:1103-10.
13. Long JA, Husted JA, Gladman DD, Farewell VT. The relationship between patient satisfaction with health and clinical measures of function and disease status in patients with psoriatic arthritis. J Rheumatol 2000;27:958-66.